About Surgeway Biosciences Private Limited
Data last updated:
Surgeway Biosciences Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 May 2023.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U46497KA2023PTC174184.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Shilpa and Hitesh Kumar Madhavkumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.76 Cr, a growth of 68% compared to the previous year. For the same year it recorded a net profit of ₹8.7 Lakh (net margin 3.2%) and EBITDA of ₹24.96 Lakh (EBITDA margin 9%).
The company is associated with 1 brand: Surgeway. As per MCA filings, the company has open charges of ₹56 Lakh on record.
For more details, the company can be reached via its website surgeway.com.
Company details
Contact details
Surgeway Biosciences Private Limited's registered office is in Bangalore, Karnataka.
- Social Media
- Registered AddressNo. 32 3rd Floor Kk Plaza, 3rd Main Hanumanthnagar, Bangalore, Karnataka, India – 560019
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Surgeway Biosciences operates one associated brand: Surgeway. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures pharmaceuticals, innovates technologies, and exports to emerging markets worldwide. | surgeway.com |
Business activity
The main business activity of Surgeway Biosciences is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Surgeway Biosciences Private Limited, buy the company report.
Financials of Surgeway Biosciences Private Limited
FY 2025 filings availableSurgeway Biosciences Private Limited reported revenue of ₹2.76 Cr (up 68% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 68% in the latest year. EBITDA rose 25% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹24.96 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹8.7 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 9% | |
| Net Profit Margin | 3.2% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Surgeway Biosciences Private Limited, buy the company report.
Board of directors of Surgeway Biosciences Private Limited
Surgeway Biosciences has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shilpa Also directs: Dorphyll Healthcare Private Limited | Director | 27 May 2023 | 3 Years 5 Months | Current |
| Hitesh Kumar Madhavkumar Also directs: Dorphyll Healthcare Private Limited | Director | 27 May 2023 | 3 Years 5 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 14 Aug 2025 | 101156728 | State Bank of India | ₹56 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Surgeway Biosciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Surgeway Biosciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Surgeway Biosciences Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Surgeway Biosciences Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Hitesh Kumar Madhavkumar was appointed as Director on 27 May 2023.
Frequently asked questions
Surgeway Biosciences is an active private limited company based in Bangalore, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 May 2023 (3+ years old) and is registered under CIN U46497KA2023PTC174184.
Surgeway Biosciences has 2 current directors:
- Shilpa - Director
- Hitesh Kumar Madhavkumar - Director
The latest financial statements of Surgeway Biosciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Surgeway Biosciences is U46497KA2023PTC174184. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Surgeway Biosciences was incorporated on 27 May 2023, making it 3+ years old. It is registered with the Registrar of Companies, Bangalore.
Hitesh Kumar Madhavkumar was appointed as Director on 27 May 2023. Shilpa was appointed as Director on 27 May 2023.
Surgeway Biosciences can be reached through the website surgeway.com. Its registered office is in Bangalore, Karnataka, India.
The registered office of Surgeway Biosciences is at No. 32 3rd Floor Kk Plaza, 3rd Main Hanumanthnagar, Bangalore, Karnataka, India – 560019.
Surgeway Biosciences operates in the pharma industry, in the drug formulation and development segment.
Surgeway Biosciences has open charges of ₹56 Lakh and no satisfied charges on record as per latest MCA filings.